Literature DB >> 29277849

Evaluating Slow-Release Oral Morphine to Narrow the Treatment Gap for Opioid Use Disorders.

M Eugenia Socías1, Evan Wood1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29277849      PMCID： PMC5794003          DOI： 10.7326/M17-2373

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  7 in total

Review 1.  Retention in medication-assisted treatment for opiate dependence: A systematic review.

Authors:  Christine Timko; Nicole R Schultz; Michael A Cucciare; Lisa Vittorio; Christina Garrison-Diehn
Journal:  J Addict Dis       Date:  2015-10-14

2.  The next epidemic--lessons from Ebola.

Authors:  Bill Gates
Journal:  N Engl J Med       Date:  2015-03-18       Impact factor: 91.245

3.  The Role of Science in Addressing the Opioid Crisis.

Authors:  Nora D Volkow; Francis S Collins
Journal:  N Engl J Med       Date:  2017-05-31       Impact factor: 91.245

Review 4.  Medication-assisted treatment of opioid use disorder: review of the evidence and future directions.

Authors:  Hilary Smith Connery
Journal:  Harv Rev Psychiatry       Date:  2015 Mar-Apr       Impact factor: 3.732

Review 5.  Update on Barriers to Pharmacotherapy for Opioid Use Disorders.

Authors:  Anjalee Sharma; Sharon M Kelly; Shannon Gwin Mitchell; Jan Gryczynski; Kevin E O'Grady; Robert P Schwartz
Journal:  Curr Psychiatry Rep       Date:  2017-06       Impact factor: 5.285

6.  From AIDS to Opioids - How to Combat an Epidemic.

Authors:  Arthur R Williams; Adam Bisaga
Journal:  N Engl J Med       Date:  2016-09-01       Impact factor: 91.245

7.  Trends in Deaths Involving Heroin and Synthetic Opioids Excluding Methadone, and Law Enforcement Drug Product Reports, by Census Region - United States, 2006-2015.

Authors:  Julie K O'Donnell; R Matthew Gladden; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-09-01       Impact factor: 17.586
  7 in total
  7 in total

1.  Successful treatment with slow-release oral morphine following afentanyl-related overdose: A case report.

Authors:  Gerrit Prinsloo; Keith Ahamad; M Eugenia Socías
Journal:  Subst Abus       Date:  2019-03-04       Impact factor: 3.716

2.  Slow release oral morphine versus methadone for opioid use disorder in the fentanyl era (pRESTO): Protocol for a non-inferiority randomized clinical trial.

Authors:  M Eugenia Socias; Evan Wood; Huiru Dong; Rupinder Brar; Paxton Bach; Sean M Murphy; Nadia Fairbairn
Journal:  Contemp Clin Trials       Date:  2020-03-16       Impact factor: 2.226

3.  Slow release oral morphine versus methadone for the treatment of opioid use disorder.

Authors:  Jan Klimas; Lauren Gorfinkel; Salvatore M Giacomuzzi; Christian Ruckes; M Eugenia Socías; Nadia Fairbairn; Evan Wood
Journal:  BMJ Open       Date:  2019-04-02       Impact factor: 2.692

4.  'Safer opioid distribution' as an essential public health intervention for the opioid mortality crisis - Considerations, options and examples towards broad-based implementation.

Authors:  Benedikt Fischer; Angelica Lee; Lenka Vojtila
Journal:  Public Health Pract (Oxf)       Date:  2020-05-26

5.  Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.

Authors:  Thomas D Brothers; John Fraser; Emily MacAdam; Brendan Morgan; Duncan Webster
Journal:  Drug Alcohol Rev       Date:  2021-08-04

6.  Fentanyl assisted treatment: a possible role in the opioid overdose epidemic?

Authors:  Geoff Bardwell; Evan Wood; Rupinder Brar
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-11-11

7.  Participants' Treatment Perspectives on a Clinical Trial on the Use of Extended-Release Naltrexone for Substance Use Disorders: Considerations for Future Clinical Research.

Authors:  Geoff Bardwell; Kaitlyn Jaffe; P Todd Korthuis; Lindsey Richardson
Journal:  J Addict Med       Date:  2021 Sep-Oct 01       Impact factor: 3.702
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.